tallózása szerző szerint "Kramer G"

A találatok rendezése: Rendezés: Találatok:

  • Circulating and tissue expression levels of YKL-40 in renal cell cancer 
    Vom Dorp F; Tschirdewahn S; Niedworok C; Reis H; Krause H; Kempkensteffen C; Busch J; Kramer G; Shariat SF; Nyirády, Péter; Rubben H; Szarvas, Tibor (2016)
    PURPOSE: Blood levels of YKL-40 are elevated in various malignancies and other inflammatory diseases. Moreover, higher YKL-40 levels, have consequently been shown to correlate with poor prognosis in several cancers. The ...
  • Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancer. 
    Szarvas, Tibor; Reis H; Kramer G; Shariat SF; Vom Dorp F; Tschirdewahn S; Schmid KW; Kovalszky, Ilona; Rubben H (2014)
    In this study, we assessed the changes and prognostic relevance of syndecan-1 (SDC1) tissue and serum levels in bladder cancer (BC). SDC1 levels were analyzed in 213 samples (119 paraffin-embedded and 79 serum samples of ...
  • Prognostic effect of serum and tissue YKL-40 levels in bladder cancer. 
    Tschirdewahn S; Reis H; Niedworok C; Nyirády Péter; Szendrői Attila; Schmid KW; Shariat SF; Kramer G; Vom Dorp F; Rubben H; Szarvas T (2014)
    OBJECTIVES: YKL-40 is a novel inflammatory serum protein shown to be associated with the presence and prognosis of several malignancies. However, its prognostic relevance has not yet been analyzed in bladder cancer (BC). ...